Joseph Frattaroli
Nessuna posizione attualmente
Patrimonio netto: 17 312 $ in data 31/03/2024
Profilo
Joseph Frattaroli is the founder of Flagship Consulting, Inc. (founded in 2010).
He was the President, Chief Executive & Financial Officer at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He is currently the Chief Financial Officer at Inhibikase Therapeutics, Inc. (2018-2024).
Mr. Frattaroli obtained his undergraduate degree from Salem State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2024 | 8 015 ( 0.13% ) | 17 312 $ | 31/03/2024 |
Precedenti posizioni note di Joseph Frattaroli
| Società | Posizione | Fine |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director of Finance/CFO | 31/03/2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Director of Finance/CFO | 06/11/2012 |
| Flagship Consulting, Inc. | Founder | - |
Formazione di Joseph Frattaroli
| Salem State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
| Flagship Consulting, Inc. |
- Borsa valori
- Insiders
- Joseph Frattaroli
